BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations. S.3217, The Restoring American Financial Stability Act, on financial reform with provisions on the regulation of over-the-counter derivatives and Congo conflict minerals Conference Report H. Rept 111-517,Wall Street Reform and Consumer Protection Act, with provisions on the regulation of over-the-counter derivatives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN CECIL FRICK | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Taxation/Internal Revenue Code TAX
The FY2011 budget proposal and provisions related to the taxation of foreign earnings of U.S. multinational corporations. S. 3816, Creating American Jobs and Ending Offshoring Act, a bill that would limit deferral for U.S. companies that move production overseas and then import products back to the United States. S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit H.R.4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010, a bill that includes extension of the R&D tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| JEAN CECIL FRICK | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
| SCOTT REID | — |
Copyright/Patent/Trademark CPT
S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies H.R.5322, Patent and Trademark Office Funding Stabilization Act of 2010, provisions related specifically to innovative technologies H.R. 4954, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Health Issues HCR
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Implementation of H.R. 4872, the Health Care and Reconciliation Act of 2010, a bill that makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act, specifically regarding the medical device tax. S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices Reform of the 510 (k) regulatory pathway H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the authorities of the FDA H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 3090, Health Equity & Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information. H.R.1032, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. S.422, Heart Disease Education, Analysis Research, and Treatment for Women Act to amend the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| JEAN CECIL FRICK | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
| SCOTT REID | — |
Medicare/Medicaid MMM
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative effectiveness research for drugs, devices, and other therapies S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and device labeling and advertising H.R. 4700, the Transparency in All Health Care Pricing Act of 2010, to provide for transparency in health care pricing H.R. 2249, the Health Care Price Transparency Promotion Act of 2009, to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs. H.R. 4803, the Patients Right to Know Act, to ensure health care consumer and provider access to certain health benefits plan information and to amend title XIX of the Social Security Act to provide transparency in hospital price and quality information
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN CECIL FRICK | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
| SCOTT REID | — |
Transportation TRA
H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEAN CECIL FRICK | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
| SCOTT REID | — |
Food Industry (safety, labeling, etc.) FOO
HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply. Includes provisions related to registration fees, device import safety fees, and unique identifier provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Labor Issues/Antitrust/Workplace LBR
S.560, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during the organizing efforts H.R. 1409, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, assist labor organizations, and to provide for mandatory injunctions for unfair labor practices during the organizing efforts
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| JEAN CECIL FRICK | — |
| STEVEN NEIL LAPIERRE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.